Concepedia

Wen Ling

WL

22

Publications

1.5K

Citations

16

H-Index

2003

Active since

Affiliations

University of Arkansas for Medical Sciences(Current)

University of Catania

Ferrarotto Hospital

Central Arkansas Veterans Healthcare System

Wen Ling is an author at University of Arkansas for Medical Sciences specializing in medicine, cell biology, and oxidative stress.

Top concepts

Publications per year

2003–2024

22

Publications

22

Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo

Shmuel Yaccoby, Wen Ling, Fenghuang Zhan et al. · Blood · 2006 · 431 citations · Full text

Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.

Shmuel Yaccoby, Michele Wezeman, Maurizio Zangari et al. · PubMed · 2006 · 158 citations

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

Angela Pennisi, Xin Li, Wen Ling et al. · American Journal of Hematology · 2008 · 138 citations · Full text

, , +16

Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation

Jumei Shi, Junru Wang, Huaien Zheng et al. · Blood Coagulation & Fibrinolysis · 2003 · 120 citations

, , +22

The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth

Angela Pennisi, Wen Ling, Xin Li et al. · Blood · 2009 · 96 citations · Full text

Rows per page

1–5 of 22